Registered Trials
-
NCT04760743
Phase 1Republic of Korea
Total Enrollment: 50
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.